1. P508 The impact of disease duration and early biologic treatment on transmural healing in Crohn's disease. (21st January 2022) Authors: Revés, J; Freire, G; Sousa, P; Primitivo, A; Nascimento, C; Morão, B; Abreu, N; Palmela, C; Glória, L; Torres, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P581 Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn's disease: European multicentre study with a propensity-score matched analysis. (30th January 2023) Authors: Revés, J; Fernandez-Clotet, A; Ordás, I; Buisson, A; Ellul, P; Elorza, A; Aduna, M; Rodríguez-Lago, I; Freire, G; Sousa, P; Primitivo, A; Delgado, I; Sousa Lajas, I; Raimundo, A; Bettencourt, P; Rimola, J; Torres, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗